Research


Re-inventing drug development: A case study of the I-SPY 2 breast cancer clinical trials program

with Sonya Das, Contemporary Clinical Trials 62 (2017) 168–174

View abstract

Accelerating Biomedical Innovation: A Case Study of the SPARK Program at Stanford University, School of Medicine

with Esther S. Kim, Paige M.C. Omura, Drug Discovery Today 22:7 (2017)

View abstract

Use of Bayesian Decision Analysis to Minimize Harm in Patient-Centered Randomized Clinical Trials in Oncology

with Vahid Montazerhodjat; Shomesh E. Chaudhuri; Daniel J. Sargent, JAMA Oncology (2017)

View abstract

New directions for the FDA in the 21st century

Biostatistics

View abstract

Buying Cures vs. Renting Health: Financing Healthcare via Consumer Loans

with Vahid Montazerhodjat and David Weinstock, Science Translational Medicine 8(2016), 327ps6

View abstract

Health, Wealth, and the 21st Century Cures Act

with Tomas Philipson and Andrew von Eschenbach, JAMA Oncology 2(2016), 17–18.

View abstract

Price, Value, and the Cost of Cancer Drugs

with Tito Fojo  , Lancet Oncology 17(2016), 3–5.

View abstract

Business Models to Cure Rare Disease: A Case Study of Solid Biosciences

with Esther Kim, Journal of Investment Management 14(2016), 87–101.

View abstract

‘Health care loans’ for Hep C cure

with David Weinstock, The Boston Globe

View abstract

Buying Cures Versus Renting Health: Financing Health Care with Consumer Loans

with Vahid Montazerhodjat and David M. Weinstock, Science Translational Medicine 8(2016), 327ps6.

View abstract

Follow me on © 2017 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.
Design by: Opus Design